1335210-25-7 Usage
Uses
Used in Pharmaceutical Industry:
(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid is used as a potential pharmaceutical candidate for its possible pharmacological or biological activity. (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid's unique structure and functional groups may contribute to its potential therapeutic effects, which require further investigation to determine its specific applications and mechanisms of action in treating various diseases or conditions.
Used in Research and Development:
(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid serves as a valuable compound in research and development for its potential applications in various scientific fields. Its unique structure and properties make it an interesting subject for studying the synthesis, modification, and evaluation of its potential biological activities, which can contribute to the advancement of knowledge in chemistry, biology, and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 1335210-25-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,5,2,1 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1335210-25:
(9*1)+(8*3)+(7*3)+(6*5)+(5*2)+(4*1)+(3*0)+(2*2)+(1*5)=107
107 % 10 = 7
So 1335210-25-7 is a valid CAS Registry Number.
1335210-25-7Relevant academic research and scientific papers
Process for Preparation of Intermediates Used for the Synthesis of HIV Integrase Inhibitor
-
Paragraph 0096-0098, (2021/01/25)
Provided herein is a process for the intermediates used for preparation of HIV Integrase Inhibitor such as Bictegravir, Dolutegravir, Cabotegravir or their pharmaceutically acceptable salts.
CONTINUES FLOW PROCESS FOR THE PREPARATION OF ACTIVE PHARMACEUTICAL INGREDIENTS - POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVES AND INTERMEDIATES THEREOF
-
, (2019/09/04)
The present invention discloses continues flow process for the preparation of polycyclic carbamoyl pyridone derivatives and intermediates thereof. In particular, the present invention discloses a process for the preparation of intermediate. Formule (V).
An Efficient and Highly Diastereoselective Synthesis of GSK1265744, a Potent HIV Integrase Inhibitor
Wang, Huan,Kowalski, Matthew D.,Lakdawala, Ami S.,Vogt, Frederick G.,Wu, Lianming
, p. 564 - 567 (2015/03/04)
A novel synthesis of GSK1265744, a potent HIV integrase inhibitor, is described. The synthesis is highlighted by an efficient construction of the densely functionalized pyridinone core as well as a highly diastereoselective formation of the acyl oxazolidine moiety. The latter exploits the target molecules ability to chelate to Mg2+, a key feature in the integrase inhibitors mechanism of action.
PROCESS FOR PREPARING CARBAMOYLPYRIDONE DERIVATIVES AND INTERMEDIATES
-
, (2011/10/13)
The present invention relates to the preparation of carbamoylpyridone derivatives and intermediates.
